| P2093 | author name string | David Langleben | |
| | Gregory P Star | |
| | Michele Giovinazzo | |
| P2860 | cites work | Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins | Q24291557 |
| | Transforming growth factor-beta1 induces endothelin-1 in a bovine pulmonary artery endothelial cell line and rat lungs via cAMP | Q28570528 |
| | Clinical classification of pulmonary hypertension. | Q30341846 |
| | BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension | Q34043809 |
| | Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. | Q34085780 |
| | Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene | Q34142690 |
| | Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension | Q34294101 |
| | Cellular and molecular pathobiology of pulmonary arterial hypertension | Q35803229 |
| | Pathologic assessment of vasculopathies in pulmonary hypertension | Q35803235 |
| | BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk | Q36116637 |
| | Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling? | Q36634716 |
| | Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension | Q36752321 |
| | Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies | Q37087907 |
| | Inhibitory Smad transcription factors protect arterial endothelial cells from apoptosis induced by BMP4. | Q40274237 |
| | An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension | Q41123021 |
| | Bone morphogenetic protein receptors | Q41270251 |
| | Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. | Q42539051 |
| | The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. | Q42823613 |
| | Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. | Q53644055 |
| | Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. | Q54237894 |
| | Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? | Q54299949 |
| | Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension | Q55670914 |
| | Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells | Q69492102 |
| | Endothelins and the lung | Q71540420 |
| | Endothelin-1 expression in long-term cultures of fetal rat calvarial osteoblasts: regulation by BMP-7 | Q73670457 |
| | Bosentan therapy for pulmonary arterial hypertension | Q77801473 |
| | Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension | Q77822568 |
| | Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension | Q77933091 |
| | Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation | Q80005826 |
| | Transforming growth factor-beta induces endothelin-1 expression through activation of the Smad signaling pathway | Q81663164 |
| | Etiology-specific endothelin-1 clearance in human precapillary pulmonary hypertension | Q82828631 |
| | Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan | Q83334055 |
| P433 | issue | 1-2 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 45-50 | |
| P577 | publication date | 2008-09-24 | |
| P1433 | published in | Vascular Pharmacology | Q7916446 |
| P1476 | title | Effects of bone morphogenic proteins and transforming growth factor-beta on In-vitro production of endothelin-1 by human pulmonary microvascular endothelial cells | |
| P478 | volume | 50 | |